Market Research Logo

Safety Needles Market: North America to Dominate the Global Market Through 2027: Global Industry Analysis and Opportunity Assessment 2017-2027

Safety Needles Market: North America to Dominate the Global Market Through 2027: Global Industry Analysis and Opportunity Assessment 2017-2027

North America is the largest market while Asia Pacific Excluding Japan is the fastest growing market in the global safety needles market

The global safety needles market is estimated to be valued at nearly US$ 4,000 Mn in 2017 and is anticipated to touch almost US$ 8,000 Mn by 2027 end, registering a CAGR of 6.9 % over the forecast period. North America is the largest regional market, which is estimated to cross US$ 1,200 Mn, or 31.1% share of the total market share in 2017 and is estimated to reach a market valuation in excess of US$ 2,500 Mn by 2027, registering a CAGR of 7.3% over the forecast period. APEJ is the fastest growing market, which is expected to grow from nearly US$ 540 Mn in 2017 to over US$ 1,100 Mn by 2027.

As the global safety needles market is replete with continuous new innovative technology and novel product launches, companies in the safety needles market across the world are actively engaged in the process of mergers and acquisitions in order to strengthen their product portfolio and cement their position in the market. Top market players are adopting the strategy of mergers and acquisitions to enhance their brand value and to develop more effective and efficient products while meeting the global standards for safety and efficiency. This will help companies increase their market share and expand their consumer base in uncharted territories.

Strategic acquisition case study – Boston Scientific and Xlumena Inc.

In 2015, Boston Scientific reached an agreement announcing the acquisition of Xlumena, a company that manufactures minimally invasive devices to carry out endoscopic ultrasound (EUS) enabled transluminal drainage of specific target areas in the gastrointestinal tract. According to the terms and conditions of the deal, besides an initial upfront payment, Boston Scientific shall also pay an additional amount to Xlumena once the FDA gives clearance to Xlumena’s HOT AXIOS device. In addition, sales milestones as per volume sales achieved in 2018 are also a part of the deal. The advanced HOT AXIOS Stent and Delivery System integrates cautery in the AXIOS stent that has been approved by the FDA. This strategic acquisition will help Boston Scientific establish its stronghold in the EUS segment.

Worldwide safety legislations regarding safety needles

In the year 1991, the Blood Borne Pathogen standard was established in the U.S. 1999 was a landmark year as anti-needlestick legislation was implemented in California, U.S. In the year 2000, Federal Anti-Needlestick legislation was passed in the U.S. In 2005, order 827/2005 was set by the Ministry of Health in Spain. In 2007, the National Health Service Reference Guide was implemented in the U.K. In the same year, Sharp Injury Protection was legislated in Germany. In 2008, Sharp Injury Protection was legislated in Canada. In the year 2010, a legislation was passed in Brazil regarding needlestick injuries. In 2011, the Amendment to Medical Care Act was passed in Taiwan that takes into account needlestick injuries. The year 2013 was the deadline for Sharps Legislation implementation in the European Union. More countries are expected to follow soon and enact legislations regarding needlestick injuries and their prevention. Government enforcement to use safety needles in various countries likely to give a boost to the global safety needles market

In order to avoid hospital acquired diseases such as HIV, Hepatitis C and Hepatitis B etc., governments in various countries are implementing stringent regulations as mentioned above. Needlestick injuries sustained from contaminated needles can result in infections from various harmful blood borne diseases. As per a report by the Program for Appropriate Technology in Health (PATH) published in 2005, due to the reuse of contaminated needles, 2 Mn Hepatitis C infections, 20 Mn Hepatitis B infections and 250,000 HIV infections are caused annually. Various government supported norms such as Needlestick Safety and Prevention Act, Needles Exchange Program and implementation of OSHA’s blood borne pathogens standards are increasing awareness among the population about diseases caused by using contaminated needles, and this factor is likely to fuel the demand for better quality safety needles.


1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Safety Needles Market Analysis Scenario
3.1. Market Volume Analysis
3.2. Pricing Analysis
3.2.1. Price Projections Per Region
3.3. Market Size (US$ Mn) and Forecast
3.3.1. Market Size and Y-o-Y Growth
3.3.2. Absolute $ Opportunity
3.4. Market Overview
3.4.1. Value Chain
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Global Trend
4.6. Worldwide Safety Legislation
4.7. Key Developments - BD Staked Needle Prefilled Syringes Development
4.8.Product Comparison: Challenges faced in using Safety Needles
4.9.NHS Evaluation: Safety-engineered Hypodermic Needles
5. Global Safety Needles Market Analysis and Forecasts, By Product Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Product Type
5.3. Y-o-Y Growth Projections By Product Type
5.4.Market Value and Volume Forecast By Product Type, 2017–2027
5.4.1. Fine Aspirating Needles
5.4.2. Biopsy Needles
5.4.3. Hypodermic Needles
5.4.4. Pen Needles
5.4.5. Suture Needles
5.4.6. IV Catheter Needles
5.4.7. Huber Needles
5.4.8. Blood Collection Needle
5.4.9. Spinal Anesthesia and epidural Needle
5.4.10. Prefilled Needle
5.4.11. A.V. Fistula Needle
5.4.12. Cannula Needles
5.5. Market Attractiveness By Product Type
6. Global Safety Needles Market Analysis and Forecasts, By Application
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Application
6.3. Y-o-Y Growth Projections By Application
6.4. Market Value and Volume Forecast By Application, 2017–2027
6.4.1. Sample Collection
6.4.2. Drug Delivery
6.4.5. Injection
6.5. Market Attractiveness By Application
7. Global Safety Needles Market Analysis and Forecasts, By Distribution Channel
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Distribution Channel
7.3. Y-o-Y Growth Projections By Distribution Channel
7.4. Market Value and Volume Forecast By Distribution Channel, 2017–2027
7.4.1. Hospital Pharmacy
7.4.2. Private Clinics
7.4.3. Retail Pharmacies and Drug Stores
7.4.4. E- Commerce
7.5. Market Attractiveness By Distribution Channel
8. Global Safety Needles Market Analysis and Forecasts, By Region
8.1. Basis Point Share (BPS) Analysis By Region
8.2. Y-o-Y Growth Projections By Region
8.3. Market Value and Volume Forecast By Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. APEJ
8.3.6. Japan
8.3.7. MEA
8.4. Market Attractiveness By Region
9. North America Safety Needles Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.1.3. Key Regulations
9.2. Market Value and Volume Forecast By Product Type, 2017–2027
9.2.1. Fine Aspirating Needles
9.2.2. Biopsy Needles
9.2.3. Hypodermic Needles
9.2.4. Pen Needles
9.2.5. Suture Needles
9.2.6. IV Catheter Needles
9.2.7. Huber Needles
9.2.8. Blood Collection Needle
9.2.9. Spinal Anesthesia and epidural Needle
9.2.10. Prefilled Needle
9.2.11. A.V. Fistula Needle
9.2.12. Cannula Needles
9.3. Market Value and Volume Forecast By Application, 2017–2027
9.3.1. Sample Collection
9.3.2. Drug Delivery
9.3.3. Injection
9.4. Market Value and Volume Forecast By Distribution Channel, 2017–2027
9.4.1. Hospital Pharmacy
9.4.2. Private Clinics
9.4.3. Retail Pharmacies and Drug Stores
9.4.4. E- Commerce
9.5.Market Value and Volume Forecast By Country, 2017–2027
9.5.1. US
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product Type
9.6.2. By Application
9.6.3. By Distribution Channel
9.6.4. By Country
9.7. Drivers and Restraints: Impact Analysis
10. Latin America Safety Needles Market Analysis and Forecast
10.1.Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Key Regulations
10.2.Market Value and Volume Forecast By Product Type, 2017–2027
10.2.1. Fine Aspirating Needles
10.2.2. Biopsy Needles
10.2.3. Hypodermic Needles
10.2.4. Pen Needles
10.2.5. Suture Needles
10.2.6. IV Catheter Needles
10.2.7. Huber Needles
10.2.8. Blood Collection Needle
10.2.9. Spinal Anesthesia and epidural Needle
10.2.10. Prefilled Needle
10.2.11. A.V. Fistula Needle
10.2.12. Cannula Needles
10.3.Market Value and Volume Forecast By Application, 2017–2027
10.3.1. Sample Collection
10.3.2. Drug Delivery
10.3.3. Injection
10.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027
10.4.1. Hospital Pharmacy
10.4.2. Private Clinics
10.4.3. Retail Pharmacies and Drug Stores
10.4.4. E- Commerce
10.5.Market Value and Volume Forecast By Country, 2017–2027
10.5.1. Argentina
10.5.2. Brazil
10.5.3. Mexico
10.5.4. Rest of Latin America
10.6.Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By Distribution Channel
10.6.4. By Country
10.7. Drivers and Restraints: Impact Analysis
11. Western Europe Safety Needles Market Analysis and Forecast
11.1.Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.1.3. Key Regulations
11.2.Market Value and Volume Forecast By Product Type, 2017–2027
11.2.1. Fine Aspirating Needles
11.2.2. Biopsy Needles
11.2.3. Hypodermic Needles
11.2.4. Pen Needles
11.2.5. Suture Needles
11.2.6. IV Catheter Needles
11.2.7. Huber Needles
11.2.8. Blood Collection Needle
11.2.9. Spinal Anesthesia and epidural Needle
11.2.10. Prefilled Needle
11.2.11. A.V. Fistula Needle
11.2.12. Cannula Needles
11.3.Market Value and Volume Forecast By Application, 2017–2027
11.3.1. Sample Collection
11.3.2. Drug Delivery
11.3.3. Injection
11.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027
11.4.1. Hospital Pharmacy
11.4.2. Private Clinics
11.4.3. Retail Pharmacies and Drug Stores
11.4.4. E- Commerce
11.5.Market Value and VolumeForecast By Country, 2017–2027
11.5.1. UK
11.5.2. France
11.5.3. Germany
11.5.4. Italy
11.5.5. Spain
11.5.6. Nordic
11.5.7. Benelux
11.5.8. Rest of Western Europe
11.6.Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By Distribution Channel
11.6.4. By Country
11.7. Drivers and Restraints: Impact Analysis
12. Eastern Europe Safety Needles Market Analysis and Forecast
12.1.Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.1.3. Key Regulations
12.2.Market Value and Volume Forecast By Product Type, 2017–2027
12.2.1. Fine Aspirating Needles
12.2.2. Biopsy Needles
12.2.3. Hypodermic Needles
12.2.4. Pen Needles
12.2.5. Suture Needles
12.2.6. IV Catheter Needles
12.2.7. Huber Needles
12.2.8. Blood Collection Needle
12.2.9. Spinal Anesthesia and epidural Needle
12.2.10. Prefilled Needle
12.2.11. A.V. Fistula Needle
12.2.12. Cannula Needles
12.3.Market Value and Volume Forecast By Application, 2017–2027
12.3.1. Sample Collection
12.3.2. Drug Delivery
12.3.3. Injection
12.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027
12.4.1. Hospital Pharmacy
12.4.2. Private Clinics
12.4.3. Retail Pharmacies and Drug Stores
12.4.4. E- Commerce
12.5.Market Value and Volume Forecast By Country, 2017–2027
12.5.1. Russia
12.5.2. Poland
12.5.3. Rest of Eastern Europe
12.6.Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By Distribution Channel
12.6.4. By Country
12.7. Drivers and Restraints: Impact Analysis
13. APEJ Safety Needles Market Analysis and Forecast
13.1.Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.1.3. Key Regulations
13.2.Market Value and Volume Forecast By Product Type, 2017–2027
13.2.1. Fine Aspirating Needles
13.2.2. Biopsy Needles
13.2.3. Hypodermic Needles
13.2.4. Pen Needles
13.2.5. Suture Needles
13.2.6. IV Catheter Needles
13.2.7. Huber Needles
13.2.8. Blood Collection Needle
13.2.9. Spinal Anesthesia and epidural Needle
13.2.10. Prefilled Needle
13.2.11. A.V. Fistula Needle
13.2.12. Cannula Needles
13.3.Market Value and Volume Forecast By Application, 2017–2027
13.3.1. Sample Collection
13.3.2. Drug Delivery
13.3.3. Injection
13.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027
13.4.1. Hospital Pharmacy
13.4.2. Private Clinics
13.4.3. Retail Pharmacies and Drug Stores
13.4.4. E- Commerce
13.5.Market Value and Volume Forecast By Country, 2017–2027
13.5.1. China
13.5.2. India
13.5.3. Australia & New Zealand
13.5.4. ASEAN
13.5.5. Rest of APEJ
13.6.Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By Distribution Channel
13.6.4. By Country
13.7. Drivers and Restraints: Impact Analysis
14. Japan Safety Needles Market Analysis and Forecast
14.1.Introduction
14.1.1. Basis Point Share (BPS) Analysis By Country
14.1.2. Y-o-Y Growth Projections By Country
14.1.3. Key Regulations
14.2.Market Value and Volume Forecast By Product Type, 2017–2027
14.2.1. Fine Aspirating Needles
14.2.2. Biopsy Needles
14.2.3. Hypodermic Needles
14.2.4. Pen Needles
14.2.5. Suture Needles
14.2.6. IV Catheter Needles
14.2.7. Huber Needles
14.2.8. Blood Collection Needle
14.2.9. Spinal Anesthesia and epidural Needle
14.2.10. Prefilled Needle
14.2.11. A.V. Fistula Needle
14.2.12. Cannula Needles
14.3.Market Value and Volume Forecast By Application, 2017–2027
14.3.1. Sample Collection
14.3.2. Drug Delivery
14.3.3. Injection
14.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027
14.4.1. Hospital Pharmacy
14.4.2. Private Clinics
14.4.3. Retail Pharmacies and Drug Stores
14.4.4. E- Commerce
14.5.Market Attractiveness Analysis
14.5.1. By Product Type
14.5.2. By Application
14.5.3. By Distribution Channel
14.6. Drivers and Restraints: Impact Analysis
15. MEA Safety Needles Market Analysis and Forecast
15.1.Introduction
15.1.1. Basis Point Share (BPS) Analysis By Country
15.1.2. Y-o-Y Growth Projections By Country
15.1.3. Key Regulations
15.2.Market Value and Volume Forecast By Product Type, 2017–2027
15.2.1. Fine Aspirating Needles
15.2.2. Biopsy Needles
15.2.3. Hypodermic Needles
15.2.4. Pen Needles
15.2.5. Suture Needles
15.2.6. IV Catheter Needles
15.2.7. Huber Needles
15.2.8. Blood Collection Needle
15.2.9. Spinal Anesthesia and epidural Needle
15.2.10. Prefilled Needle
15.2.11. A.V. Fistula Needle
15.2.12. Cannula Needles
15.3.Market Value and Volume Forecast By Application, 2017–2027
15.3.1. Sample Collection
15.3.2. Drug Delivery
15.3.3. Injection
15.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027
15.4.1. Hospital Pharmacy
15.4.2. Private Clinics
15.4.3. Retail Pharmacies and Drug Stores
15.4.4. E- Commerce
15.5.Market Value and Volume Forecast By Country, 2017–2027
15.5.1. GCC Countries
15.5.2. South Africa
15.5.3. North Africa
15.5.4. Rest of MEA
15.6.Market Attractiveness Analysis
15.6.1. By Product Type
15.6.2. By Application
15.6.3. By Distribution Channel
15.6.4. By Country
15.7. Drivers and Restraints: Impact Analysis
16. Competition Landscape
16.1. Competition Dashboard
16.2. Market Share Analysis By Company (2016)
16.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
16.3.1. Medtronic
16.3.2. Becton, Dickinson and Company
16.3.3. Boston Scientific Corporation
16.3.4. Smith Medical
16.3.5. Argon Medical Devices, Inc.
16.3.6. Novo Nordisk A/S
16.3.7. Terumo Corporation
16.3.8. NIPRO Medical Corporation
16.3.9. B. Braun Melsungen AG
17. Assumptions and Acronyms Used
18. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report